術中神経モニタリングの市場規模、シェア、成長分析、製品・サービス別、ソースタイプ別、用途別、モダリティ別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

術中神経モニタリングの世界市場規模は、2022年に31億2,000万米ドルと評価され、2023年の32億7,000万米ドルから2031年には47億6,000万米ドルに成長し、予測期間中（2024-2031年）のCAGRは4.8%で成長すると予測されています。

術中神経モニタリングの世界市場は、2022年から2030年にかけてCAGR4.9％を記録すると予測されており、その原動力は、手術中の神経系のリアルタイムモニタリングと評価における重要な役割です。この革新的な技術は、特に脳、脊髄、末梢神経を危険にさらす可能性のあるリスクの高い手術において、神経系の完全性と機能を効果的に評価するために不可欠です。術中神経モニタリングには、筋電図、脳波、誘発電位などのさまざまな技術が含まれます。同市場は、患者の安全に対する意識の高まりと技術の進歩に後押しされ、成長が見込まれています。さらに、脳卒中、てんかん、アルツハイマー病、パーキンソン病などの慢性神経疾患の発生率が上昇していることも、神経モニタリング・ソリューションの需要をさらに高めています。世界保健機関（WHO）は、世界中で年間約1,500万人が脳卒中を経験していることを明らかにし、モニタリング装置の強化が世界的に求められていることを強調しています。米国では、複雑な外科手術における患者の安全性が重視されるようになり、手術結果の改善や患者の全体的な体験の向上における神経モニタリングの重要性が浮き彫りになったことを反映して、術中神経モニタリング市場も堅調な成長軌道を維持すると予想されます。技術革新、意識の高まり、神経疾患の蔓延といった累積的要因が、術中神経モニタリング市場を今後数年のうちに力強く前進させると思われます。

目次

イントロダクション

• 調査の目的
• 定義
• 市場範囲

調査手法

• 情報調達
• 二次データソースと一次データソース
• 市場規模予測
• 市場の想定と制限

エグゼクティブサマリー

• 市場概要見通し
• 供給需要動向分析
• セグメント別機会分析

市場力学と見通し

• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• ポーターの分析

主な市場の考察

• 技術分析
• 価格分析
• バリューチェーン分析
• 市場のエコシステム
• 貿易分析
• サプライチェーン分析
• ケーススタディ分析
• 特許分析
• 顧客と購買基準の分析
• 規制情勢
• イノベーションマトリクス
• 主な投資の分析
• 主な成功要因
• 競合の程度

術中神経モニタリング市場：製品とサービス別

• 市場概要
• システム
• アクセサリー
• サービス

術中神経モニタリング市場：ソースタイプ別

• 市場概要
• 内部モニタリング
• 外部モニタリング

術中神経モニタリング市場：用途別

• 市場概要
• 脊椎手術
• 脳神経手術
• 整形外科手術
• 耳鼻咽喉科手術
• 血管手術
• その他の手術

術中神経モニタリング市場：モダリティ別

• 市場概要
• 運動誘発電位（MEP）
• 体性感覚誘発電位（SSEP）
• 脳波検査（EEG）
• 筋電図検査（EMG）
• 脳幹聴覚誘発電位（BAEP）
• 視覚誘発電位（VEP）

術中神経モニタリング市場：エンドユーザー別

• 市場概要
• 病院
• 外来手術センター（ASC）

術中神経モニタリング市場規模：地域別

• 市場概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ（MEA）
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ地域

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場における最近の活動
• 主要企業の市場シェア（2023年）

主要企業プロファイル

• Natus Medical Incorporated（US）
• Accurate Monitoring（US）
• Neuromonitoring Technologies（US）
• Medtronic（Ireland）
• NuVasive, Inc.（US）
• SpecialtyCare（US）
• Cadwell Industries, Inc.（US）
• Alpha Omega Engineering, Inc.（US）
• Biotronic NeuroNetwork（US）
• IntraOp Medical Corporation（US）
• NeuroWave Systems, Inc.（US）
• Integra LifeSciences Corporation（US）
• Zynex, Inc.（US）
• Medtronic（Ireland）
• Stryker Corporation（US）
• Nerve Monitoring Services, Inc.（US）
• Neurodiagnostic Services（US）
• Aesculap, Inc.（US）
• Elekta AB（Sweden）
• OrLive（US）
• Stimwave Technologies（US）

Global Intraoperative Neuromonitoring Market size was valued at USD 3.12 billion in 2022 and is poised to grow from USD 3.27 billion in 2023 to USD 4.76 billion by 2031, growing at a CAGR of 4.8% during the forecast period (2024-2031).

The global intraoperative neuromonitoring market is projected to experience a compound annual growth rate (CAGR) of 4.9% from 2022 to 2030, driven by its critical role in real-time monitoring and assessment of the nervous system during surgeries. This innovative technique is essential for the effective evaluation of the integrity and function of the nervous system, particularly in high-risk operations that may jeopardize the brain, spinal cord, and peripheral nerves. Intraoperative neuromonitoring encompasses various techniques, including electromyography, electroencephalography, and evoked potentials. The market is poised for growth, fueled by increasing awareness of patient safety and advancements in technology. Additionally, the rising incidence of chronic neurological disorders, such as stroke, epilepsy, Alzheimer's, and Parkinson's disease, further underscores the demand for neuromonitoring solutions. The World Health Organization highlights that approximately 15 million people worldwide experience a cerebral stroke annually, highlighting the global need for enhanced monitoring devices. In the United States, the intraoperative neuromonitoring market is also expected to sustain a robust growth trajectory, reflecting a growing emphasis on patient safety during complex surgical procedures, underscoring the importance of neuromonitoring in improving surgical outcomes and enhancing the overall patient experience. The cumulative factors of technological innovation, heightened awareness, and the prevalence of neurological disorders are set to firmly propel the intraoperative neuromonitoring market forward in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intraoperative Neuromonitoring market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Intraoperative Neuromonitoring Market Segmental Analysis

Global Intraoperative Neuromonitoring Market is segmented by Products and Services, Source Type, Application, Modality, End User, and region. Based on Products and Services, the market is segmented into Systems, Accessories, and Services. Based on Source Type, the market is segmented into Insourced Monitoring, and Outsourced Monitoring. Based on Application, the market is segmented into Spinal Surgery, Neurosurgery, Orthopedic Surgery, ENT Surgery, Vascular Surgery, and Other surgeries. Based on Modality, the market is segmented into Motor evoked potentials (MEPs), Somatosensory evoked potentials (SSEPs), Electroencephalography (EEG), Electromyography (EMG), Brainstem auditory evoked potentials (BAEPs), and Visual evoked potentials (VEPs). Based on End User, the market is segmented into Hospitals, and Ambulatory Surgical Centers (ASCs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Intraoperative Neuromonitoring Market

The global intraoperative neuromonitoring market is experiencing robust growth driven by the increasing aging population, which is more vulnerable to chronic illnesses like heart disease, diabetes, and neurological disorders. As healthcare providers aim to enhance surgical outcomes and patient safety, advanced neurosurgery devices and less invasive surgical technologies are becoming essential. Innovations such as the NIM Vital system provide real-time nerve status information, optimizing surgical strategies and improving patient quality of life. Furthermore, the rising trend of medical tourism and escalating healthcare investments in developing regions present lucrative opportunities, while chronic health challenges driven by modern lifestyles further stimulate demand for neuromonitoring solutions.

Restraints in the Global Intraoperative Neuromonitoring Market

The Global Intraoperative Neuromonitoring (IONM) market faces significant restraints primarily due to the high costs associated with IONM devices and procedures. Prices for EEG devices range from US$ 1,000 to over US$ 25,000, creating budget challenges for healthcare facilities, leading many to opt for refurbished devices rather than investing in new technology. Additionally, a shortage of trained professionals to manage and maintain these advanced monitoring systems further hampers market growth. Compounding these issues is the lack of awareness regarding the benefits of IONM, especially in developing economies, which restricts adoption and ultimately limits market expansion.

Market Trends of the Global Intraoperative Neuromonitoring Market

The Global Intraoperative Neuromonitoring (IONM) market is experiencing a significant upward trend post-pandemic, fueled by a resurgence in elective surgeries and heightened awareness of IONM's benefits to patient safety and surgical outcomes. Technological advancements in IONM equipment are further driving this market, offering improved accuracy and ease of use, which enhances the affordability and accessibility of these services. As healthcare providers increasingly incorporate IONM into surgical protocols, the market is poised for robust growth, reflecting a collective shift towards enhanced patient monitoring and safety during surgical procedures worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Trade Analysis
• Supply chain Analysis
• Case study Analysis
• Patent Analysis
• Customer & Buying Criteria Analysis
• Regulatory Landscape
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Intraoperative Neuromonitoring Market by Products and Services

• Market Overview
• Systems
• Accessories
• Services

Intraoperative Neuromonitoring Market by Source Type

• Market Overview
• Insourced Monitoring
• Outsourced Monitoring

Intraoperative Neuromonitoring Market by Application

• Market Overview
• Spinal Surgery
• Neurosurgery
• Orthopedic Surgery
• ENT Surgery
• Vascular Surgery
• Other surgeries

Intraoperative Neuromonitoring Market by Modality

• Market Overview
• Motor evoked potentials (MEPs)
• Somatosensory evoked potentials (SSEPs)
• Electroencephalography (EEG)
• Electromyography (EMG)
• Brainstem auditory evoked potentials (BAEPs)
• Visual evoked potentials (VEPs)

Intraoperative Neuromonitoring Market by End User

• Market Overview
• Hospitals
• Ambulatory Surgical Centers (ASCs)

Intraoperative Neuromonitoring Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Natus Medical Incorporated (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accurate Monitoring (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neuromonitoring Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NuVasive, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SpecialtyCare (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cadwell Industries, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alpha Omega Engineering, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronic NeuroNetwork (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IntraOp Medical Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroWave Systems, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zynex, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nerve Monitoring Services, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neurodiagnostic Services (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aesculap, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elekta AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OrLive (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stimwave Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments